Page 2 - Best Neuroblastoma doctors: TOP 36 doctors

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Miriam Ben-Harush is an internationally recognized specialist in Pediatric Oncology and Bone Marrow Transplantation at Ruth Rappaport Children's Hospital.

• Director of Pediatric Division at Rambam Medical Center
• Recipient of the Chevalier de la Legion d'Honneur in France
• Named one of the world's most caring doctors by the World Medical Association
• Member of children's oncology groups in the USA and Europe

Dr. Hodaya Cohen is a board-certified obstetrician-gynecologist at Hadassah Medical Center.

• Highly experienced in managing all aspects of women's health
• Provides comprehensive and compassionate care for her patients
• Specializes in obstetrics and gynecology

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Specialized in pediatric hematology and oncology with deep expertise in neuroblastoma – Dr. Dogru works at Biruni University Hospital.

• Board-certified pediatric hematologist with over 20 years of experience of experience
• Trained at top institutions including Hacettepe and Istanbul University
• Member of prestigious professional groups like EBMT and Turkish Pediatric Hematology Association
• Extensive experience in bone marrow transplantation procedures

Dr. Apak has 26 years of experience focused on pediatric oncology, with expertise in neuroblastoma treatment at Biruni University Hospital.

• Specialized in pediatric hematology and oncology since 1994
• Pioneered CAR T-cell therapy and bone marrow transplants
• Authored 75+ international publications on pediatric cancers
• Former head of Pediatric Hematology-Oncology at Cerrahpaşa
• Active academic board member for Istanbul University

Prof. Metin Demirkaya specializes in pediatric oncology with over 27 years of experience of experience, currently practicing at Medicana Bursa Hospital.

• Completed pediatric oncology residency at Bursa Uludag University
• Former assistant and associate professor at Bursa Uludag University
• Expertise in pediatric hematology-oncology and bone marrow transplantation
• Member of the faculty at one of Turkey's leading medical schools

Professor Yilmaz specializes in pediatric neuroblastoma with research at Harvard and MD Anderson. She focuses on cell therapies and genetic pathways in childhood cancers.

• Trained at top US institutions including Harvard and MD Anderson
• Research focuses on neuroblastoma genetics and cell therapies
• Member of European Association for Cancer Research
• Professor in Pediatric Hematology/Oncology

32 years of experience specializing in pediatric hematology and oncology – Dr. Lopez Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe.

• Expert in treating bone and brain tumors in children
• Specialized training at the University of Maryland
• Authored numerous scientific publications
• Previous leadership role at Clínica San Rafael

Dr. Shruti Kate specializes in pediatric tumors, including neuroblastoma, with training at Tata Memorial Hospital – India's leading cancer center.

• DM in Medical Oncology from Tata Memorial Hospital
• Expert in immunotherapy and metronomic therapy for advanced cancers
• Member of ASCO, ESMO, and other top oncological societies
• Presented lung cancer research at World Conference on Lung Cancer

Over 31 years of experience specializing in pediatric oncology – Dr. Lopez Ibor leads the Hematology & Pediatric Oncology Unit at HM Hospitales in Madrid, focusing on severe childhood cancers.

• Specializes in neuroblastoma and hematological disorders in children
• Trained at top institutions including the University of Maryland
• Head of two foundations improving children's treatment quality
• Consultant for WHO and UNESCO
• Active member of International Society of Pediatric Oncology

Prof. Jürgen Kiwit is a top German neurosurgeon with over 35 years of experience of experience and specializes in brain and spinal cord tumors at Meoclinic Berlin.

• Head of Neurosurgery Department at Meoclinic Berlin
• Specializes in minimally invasive surgeries and anti-pain therapy
• Trained at National Hospital for Neurology and Neurosurgery in the UK
• Member of German Society of Neurosurgery and American Association of Neurological Surgeons

Expert pediatric hematologist-oncologist specializing in neuroblastoma at Artemis Hospitals.

• Specializes in bone marrow transplants for pediatric cases
• Focuses on advanced treatment for neuroblastoma
• Works at a renowned facility with cutting-edge technology

Head of the Department of Pediatric Oncology at the prestigious Charité hospital – Europe's largest university hospital.

• Specializes exclusively in pediatric cancers like neuroblastoma
• Leads a major oncology department in a top-tier research center
• Access to the latest clinical trials and treatments